Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas (Q46265264)

20 December 2017

title

Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas (English)

1 reference

20 December 2017

author name string

Fatma Silan

1

1 reference

20 December 2017

Yener Gultekin

2

1 reference

20 December 2017

Sinem Atik

3

1 reference

20 December 2017

Davran Kilinc

4

1 reference

20 December 2017

Cabir Alan

5

1 reference

20 December 2017

Fazilet Yildiz

6

1 reference

20 December 2017

Ahmet Uludag

7

1 reference

20 December 2017

Ozturk Ozdemir

8

1 reference

20 December 2017

publication date

24 May 2011

1 reference

20 December 2017

Molecular Biology Reports

published in

1 reference

20 December 2017

volume

39

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

1595-1599

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11033-011-0898-8

exact match

0 references

cites work

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Activation of signal pathways and the resistance to anti-EGFR treatment in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

KRAS and BRAF mutations in prostate carcinomas of Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Tumoral tissue specific promoter hypermethylation of distinct tumor suppressor genes in a case with nonsmall cell lung carcinoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Effects of prostate-specific antigen testing on familial prostate cancer risk estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Mutational activation of the c-K-ras gene in human pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

International comparison on ras gene mutations in latent prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Molecular genetics of prostate cancer: new prospects for old challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Genitourinary cancer predisposition syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Epigenetic mechanisms in the biology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0898-8

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

21 January 2018

1 reference

12 December 2020

Gene expression correlates of clinical prostate cancer behavior

1 reference

12 December 2020

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

12 December 2020

1 reference

12 December 2020

Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. 1990.

1 reference

12 December 2020

Comparison of ras activation in prostate carcinoma in Japanese and American men

1 reference

12 December 2020

Fatherhood and incident prostate cancer in a prospective US cohort

1 reference

12 December 2020

[The survival analysis of metastatic prostate cancer]

1 reference

12 December 2020

Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis

1 reference

12 December 2020

10.1007/S11033-011-0898-8

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

21607617

1 reference

20 December 2017